A combinação de T-DXd com Sotorasib demonstrou eficácia promissora em estudos pré-clínicos de câncer de pulmão de não pequenas células com mutação KRAS G12C – Oncodaily
A combinação de T-DXd com Sotorasib demonstrou eficácia promissora em estudos pré-clínicos de câncer de pulmão de não pequenas células com mutação KRAS G12C.
Conteudo completo do artigo
T-DXd Plus Sotorasib in KRAS G12C-Mutant NSCLC showed durable preclinical tumor regressions and highlighted HER2 testing gaps. , ADCs, Antibody drug conjugates, HER2, HER2 expression, HER2 IHC, KRAS G12C, KRAS G12C-mutant NSCLC, KRAS inhibitor resistance, Lung cancer, NSCLC, OncoDaily Lung, Precision Oncology, preclinical oncology, Sotorasib, T-Dxd, targeted therapy, Thoracic Oncology, Trastuzumab deruxtecan, xenograft models
Produtos relacionados com este artigo
Estes produtos foram associados automaticamente a partir do titulo, resumo e conteudo do artigo.
Perguntas frequentes
Which products are related to this article?
The system matched these relevant products from the article content: Lucius Sotorasib – Compre online SOTOLDX Sotorasib 120mg.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.